New Analysis from Global Industry Analysts Reveals Steady Growth for G-Protein Coupled Receptors (GPCRs), with the Market to Reach $3.7 Billion Worldwide by 2026

SAN FRANCISCO, March 22, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "G-Protein Coupled Receptors (GPCRs) - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

FACTS AT A GLANCE
What's New for 2022?

• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to our digital archives and MarketGlass Research Platform
• Complimentary updates for one year

Edition: 20; Released: February 2022
Executive Pool: 923
Companies: 52 - Players covered include Abcam plc; Addex Pharmaceuticals Ltd.; Arena Pharmaceuticals Inc.; Becton-Dickinson and Company; Eurofins DiscoverX Corporation; HD Biosciences Co., Ltd; Merck KGaA; Perkin Elmer Inc; Promega Corporation; QIAGEN N.V.; Thermo Fisher Scientific, Inc. and Others.
Coverage: All major geographies and key segments
Segments: Product (Cell Lines, Detection Kits, Cell Culture Reagents, Ligands); Assay Type (cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays, Other Assay Types); Application (Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research, Other Applications)
Geographies: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry

ABSTRACT-

Global G-Protein Coupled Receptors (GPCRs) Market to Reach $3.7 Billion by 2026
G-protein-coupled receptors (GPCRs) represent signal-transducing molecules that transmit signals to cells. They play a key role in converting extracellular stimulus into intracellular responses, and are therefore responsible for all physiological processes. Growth in the global market is set to be fueled by increased adoption of the receptors in drug discovery. There are right now quite a few drug candidates under preclinical and clinical studies and also a good number of approved drugs, which are driving the need for GPCR assays and screening for drug development. There is also a strongly growing demand for related assays due to growing number of biological drugs, biased agonists and allosteric modulators which target these receptors. Market growth is also anticipated to be driven by increased use of GPCRs for decoding metastasis and growth of tumors and developing effective lines of treatment. Increasing prevalence of cardiovascular and respiratory diseases and such other lifestyle-induced issues also promotes market growth. Additionally, research studies targeting orphan GPCRs are seen as a lucrative area of focus.

Amid the COVID-19 crisis, the global market for G-Protein Coupled Receptors (GPCRs) estimated at US$2.9 Billion in the year 2022, is projected to reach a revised size of US$3.7 Billion by 2026, growing at a CAGR of 5.7% over the analysis period. Cell Lines, one of the segments analyzed in the report, is projected to record a 5.6% CAGR and reach US$1.5 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Detection Kits segment is readjusted to a revised 6.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.1 Billion in 2022, While China is Forecast to Reach $296.6 Million by 2026
The G-Protein Coupled Receptors (GPCRs) market in the U.S. is estimated at US$1.1 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$296.6 Million by the year 2026 trailing a CAGR of 8.4% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR. North America is the largest GPCR market currently, owing to factors such as significant investments in cancer studies, increased emphasis on drug discovery and speedy approval of GPCR targeted drugs in the region. Growth in the Asia-Pacific region is set to be propelled by burgeoning population, rising incident of cancer, and increasing focus on contract research activities.

Cell Culture Reagents Segment to Reach $601.6 Million by 2026
In the global Cell Culture Reagents segment, USA, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$370.6 Million will reach a projected size of US$518.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$55.9 Million by the year 2026.
More

MarketGlass™ Platform
Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.

Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android

About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.

CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
Email: [email protected]

LINKS
Join Our Expert Panel
https://www.strategyr.com/Panelist.asp

Connect With Us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./

Follow Us on Twitter
https://twitter.com/marketbytes

Journalists & Media
[email protected]

SOURCE Global Industry Analysts, Inc.